The Impact of Fred’s Team
Imagine a world without cancer
100% of every dollar raised through Fred’s Team goes directly to research and clinical trials at MSK.
MSK’s world-leading expertise
MSK is home to clinical experts in more than 400 types of cancer. The specialized care that MSK provides truly makes a difference for people with cancer.
Runners choose what to support
Fred’s Team gives runners the ability to choose which cancer type or area of research to support with their fundraising dollars.
Nearly 2,000 clinical trials are underway at MSK at a given time, and this level of innovation and progress wouldn’t be possible without support from Fred’s Team.
–Luis Diaz Jr., MD MSK physician-scientist
Meet Liz
The Aubrey Fund for Pediatric Cancer Research
Since 1997, Fred’s Team has raised more than $35 million for the Aubrey Fund, which is named after Fred’s Team runner and pediatric cancer survivor Aubrey Barr.
You make an impact that goes far beyond the finish line
When you run with Fred’s Team, you decide where the money you raise goes. 100% of every dollar fuels the work of MSK doctors and scientists who are world-leading experts in the cancer type or area of research you choose. Learn more about some of the research areas supported by Fred’s Team runners.
Driving progress together
By funding MSK’s greatest needs, Fred’s Team runners empower clinical and research leaders to quickly bring resources to priority initiatives that have transformative potential, ensuring that every dollar makes an impact, fast.
Building brighter futures
MSK Kids sees more children and young adults with cancer than any other pediatric program in the country. With your help, our experts are developing better treatments designed specifically for young people and their unique needs.
Bringing hope for new cures
Support from Fred’s Team accelerates advances that benefit people with breast cancer worldwide — from innovations in early detection to new treatments for people with stage 4 disease.
Tackling the toughest questions
By 2030, colorectal cancer cases in people under 50 are expected to nearly double. Funding from Fred’s Team is helping MSK researchers answer questions to better understand why, and learn how to reverse this trend.